JPRN-UMIN000008090已完成4 期
A study on the procedure for treatment switch to epoetin beta pegol in the treatment of renal anemia in maintenance hemodialysis patients - A study on the procedure for treatment switch to epoetin beta pegol
Faculty of medicine, University of Miyazaki0 个研究点目标入组 30 人开始时间: 2012年6月3日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have uncontrollable hypertension Patients with heart failure (NYHA functional class 3 or 4) Women who are pregnant, breastfeeding, or possibly pregnant. Patients who have known serious allergy or serious drug allergy (shock, anaphylactoid symptoms) Patients who have malignant tumor (including hematologic malignancy), severe infection, systemic hematologic disease (e.g. myelodysplastic syndrome, hemoglobinopathy), hemolytic anemia, or apparent hemorrhagic lesion such as gastrointestinal bleeding Patients who have received CERA before enrollment Patients whose AST or ALT level was100 IU/L or higher in the latest examination before enrollment Patients who received red blood cell transfusion within 16 weeks prior to enrollment Patients who are scheduled for surgery that may cause massive bleeding during the study period Patients who are judged ineligible by the investigator/sub-investigator
研究者
相似试验
已完成
不适用
A clinical trial of introduction and adjustment of insulin Degludec in hospitalized patients with type 2 diabetestype 2 diabetesJPRN-UMIN000035758Department of Diabetes and Endocrinology, Kansai Rosai Hospital34
招募中
不适用
The clinical study associated with the treatment effects and effectiveness prediction of subretinal neovascularization lesion.Age-related Macular DegenerationJPRN-UMIN000014436Department of Ophthalmology and Visual Sciences Yamagata100
招募中
1 期
VECTORS – A study to evaluate transmural healing as a treatment target in Crohn’s diseaseModerately to Severely Active Crohn’s DiseaseMedDRA version: 20.0Level: PTClassification code: 10011401Term: Crohn's disease Class: 100000004856CTIS2023-509096-16-00Alimentiv Inc.266
已完成
2 期
Effect of treatment using Takra in the management of Grahani Dosha (Irritable bowel syndrome)CTRI/2021/01/030781All India Institute of Ayurveda
已完成
2 期
De-escalation and stopping treatment of imatinib, nilotinib or sprycel in chronic myeloid leukaemiaTopic: National Cancer Research NetworkSubtopic: Haematological OncologyDisease: Leukaemia (chronic)Chronic myelogenous leukaemiaCancerISRCTN74084226niversity of Liverpool (UK)168